Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D Haering
Switching Therapy to Fingolimod Improves Clinical and Mri Outcomes
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Related publications
Extensive Multiple Sclerosis Reactivation After Switching From Fingolimod to Rituximab
Case Reports in Neurological Medicine
Predictors for Multiple Sclerosis Relapses After Switching From Natalizumab to Fingolimod
Multiple Sclerosis
Neurology
Early Antiretroviral Therapy Improves Neurodevelopmental Outcomes in Infants
AIDS
Infectious Diseases
Allergy
Immunology
Doxycycline Improves Clinical Outcomes During Cystic Fibrosis Exacerbations
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
M2 Occlusions as Targets for Endovascular Therapy: Comprehensive Analysis of Diffusion/Perfusion MRI, Angiography, and Clinical Outcomes
Journal of NeuroInterventional Surgery
Medicine
Surgery
Neurology
Comment On: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
Drugs
Pharmacology
Fingolimod Induces Neurogenesis in Adult Mouse Hippocampus and Improves Contextual Fear Memory
Translational Psychiatry
Psychiatry
Molecular Neuroscience
Biological Psychiatry
Mental Health
Cellular
Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
Medicina
Medicine
Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab Does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
